Sex influence in lipodystrophy of HIV-infected patients and its association with cardiovascular risk factors;Impacto del sexo en el síndrome de lipodistrofia en pacientes con infección por el VIH y su asociación con factores de riesgo cardiovascular

Anales de Medicina Interna

Volumn 24, Issue 4, 2007, Pages 168-172

  Pedro Botet Montoya, Juan ^a,b   Knobel Freud, H ^a   Montero, M ^a   Jerico Alba C ^a   Guelar Grimberg, A ^a   Pedro Botet Montoya, J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

Antiretroviral therapy; Cardiovascular risk factors; HIV; Lipodystrophy

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOALPHALIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; LIPID STORAGE; LIPOATROPHY; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT DEPARTMENT; PREVALENCE; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE; AGE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; EVALUATION; HIV ASSOCIATED LIPODYSTROPHY; MIDDLE AGED; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 35348913202     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tomás Abadal L. Riesgo cardiovascular en la menopausia: mito, paradoja o realidad. Importancia de las observaciones clínicas frente a la interpretación de los datos estadísticos. Rev Esp Cardiol 1999; 52: 463-6.
2. Polk DM, Naqvi TZ. Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation. Curr Cardiol Rep 2005; 7: 166-172.
3. Marrugat J, Sala J, Masià R, Pavesi M, Gines G, Valle V, et al. Mortality differences between men and women following first myocardial infarction. JAMA 1998; 16: 1405-9.
4. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med 1999; 34: 226-32.
5. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998; 280: 1843-8.
6. Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord 2001; 25: 1047-56.
7. Lawlor DA, Ebrahim S, Whincup M, Sterne J, Papacosta O, Wannamethee G, et al. Sex differences in body fat distribution and carotid intima media thickness: Cross sectional survey using data from the British regional heart study. J Epidemiol Community Health 2004: 58; 700-4.
8. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced HIV infection. N Engl J Med 1998; 338: 853-60.
9. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al; Swiss HIV Cohort Study. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366: 378-84.
10. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:51-8.
11. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D; the Clinical Epidemiology Group from the French Hospital Database. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003; 17: 2479-86.
12. Friis-Moller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, et al. Cardiovascular disease risk factors in HIV patients -association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17: 1179-93.
13. Carr A. HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management. AIDS 2003; 17 (Supl.1): 141-8.
14. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352: 48-62.
15. Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, Gritti F, et al. Gender differences in antirretroviral-drug related adipose tissue alterations: Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34: 58-61.
16. The Data Collection on Adverse Events of Ant-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 340: 1993-2003.
17. Hadigan C, Meigs J, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32: 130-9.
18. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
20. Anonymous. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26 (Supl.1): S5-20.
21. Centers for Disease Control and Prevention: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41 (RR-17): 1-19.
22. Tien PC, Cole SR, Williams CM, Li R, Justman JE, Cohen MH, et al. Incidence of lipoatrophy and lipohypertrophy in the women's integrance HIV study. J Acquir Immnune Defic Syndr 2003; 34: 461-6.
23. Dolan SE, Hadigan C, Killilea KM, Sullivan MP, Hemphill L, Lees RS, et al. Increased cardiovascular disease risk indices in HIV-Infected women. J Acquir Immune Defic Syndr. 2005;39: 44-54.
24. Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis 2005; 40: 1492-9.
25. Jacobson D, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clin Infect Dis 2005; 40: 1837-45.
26. Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, et al. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Medicine 2003; 4: 293-301.
27. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: A case-control study. Lancet 2003; 361: 726-35.